People: Abiomed Inc (ABMD.O)

ABMD.O on Nasdaq

35.10USD
21 Nov 2014
Price Change (% chg)

$0.05 (+0.14%)
Prev Close
$35.05
Open
$35.56
Day's High
$35.74
Day's Low
$34.70
Volume
383,410
Avg. Vol
311,632
52-wk High
$35.74
52-wk Low
$20.29

Search Stocks

Thomas, Paul 

Brief Biography

Mr. Paul G. Thomas is an Independent Director of Abiomed Inc., since May 2011. Mr. Thomas has been the Chief Executive Officer of Roka Bioscience, Inc. since September 2009. Previously he served as Chairman, Chief Executive Officer, and President of LifeCell Corporation from October 1998 until August 2008. Prior to joining LifeCell, Mr. Thomas held various senior positions during a 15-year tenure with the Pharmaceutical Products division of Ohmeda Inc. Mr. Thomas currently serves on the Board of Directors of Aegerion Pharmaceuticals, Inc. and was a member of the Board of Directors of Orthovita, Inc. until its sale in June 2011 to Stryker Corporation. Mr. Thomas received his Master of Business Administration from Columbia University, and completed his postgraduate studies in chemistry at the University of Georgia. He received his Bachelor of Science in Chemistry from St. Michael’s College.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Minogue

4,606,670

Robert Bowen

1,173,660

David Weber

1,492,500

William Bolt

1,183,400

Andrew Greenfield

536,074

Michael Howley

1,331,210
As Of 30 Mar 2014
Search Stocks